摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Tyrosine--hydrogen iodide (1/1) | 29592-76-5

中文名称
——
中文别名
——
英文名称
Tyrosine--hydrogen iodide (1/1)
英文别名
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;hydroiodide
Tyrosine--hydrogen iodide (1/1)化学式
CAS
29592-76-5
化学式
C9H12INO3
mdl
——
分子量
309.1
InChiKey
FLEQANSZVWQQRM-QRPNPIFTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.96
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    83.6
  • 氢给体数:
    4
  • 氢受体数:
    4

文献信息

  • ANTIBACTERIAL AGENT FOR TREATING INFECTIOUS DISEASES OF BACTERIAL ORIGIN
    申请人:Respublikanskoe Gosudarstvennoe Predpriyatie "Nauchnyj Centr Protivoinfekcionnyh Preparatov" Komiteta Promyshlennosti Ministerstva Industrii
    公开号:EP2722053A1
    公开(公告)日:2014-04-23
    The invention relates to medicine, namely to the antimicrobial agent for the treatment of infectious bacterial diseases including hospital infections and drug-resistant TB which represents the ion nanostructured complex (INSC) synthesized from carbohydrates proteins and/or polypeptides (albumins, interleukins, interferons, signaling proteins, etc), which are to enhance the antimicrobial activity in vivo, by activating immune cells that contain at least one terminal amino acid such as Phe, Ala, Val, Ala, Leu, Ile, and others with electron-donor functional groups, iodine and halides of the alkali and alkaline earth elements in the fourth stage at a certain ionic strength; an antibacterial agent increases: the susceptibility of bacteria, including antibiotic-resistant, to antibiotics; activity of monocytes and macrophages; efficiency of antibiotic treatment of hospital infections and drug-resistant TB; it also has antiviral activity, stimulates hematopoietic function of bone marrow; has an antitumor effect and radioprotective properties; in acceptable concentrations of components can be used as non-pharmaceutical agent (BAFS or parapharmaceutical); is presented in the pharmacological form suitable for parenteral, oral, external, or other application. INSC has the formula [(Ln (MeI3) +) y [Me (Lm) I] + x} (Cl-) y + x + k] with M = 30-300 kDa.
    本发明涉及医学,即用于治疗包括医院感染和耐药结核病在内的传染性细菌疾病的抗菌剂,它是由碳水化合物蛋白质和/或多肽(白蛋白、白细胞介素、干扰素、信号蛋白等)合成的离子纳米结构复合物(INSC),通过激活至少含有一个末端氨基酸(如Phe、Ala、Val、Ala、Leu、Iu)的免疫细胞,增强体内的抗菌活性、等)合成的纳米结构复合物(INSC),通过激活至少含有一个末端氨基酸(如 Phe、Ala、Val、Ala、Leu、Ile 等)的免疫细胞,使其在一定的离子强度下,在第四阶段具有电子供体官能团、和碱及碱土元素的卤化物,从而增强体内的抗菌活性;增加抗菌剂:它还具有抗病毒活性,刺激骨髓造血功能;具有抗肿瘤作用和放射保护特性;在可接受的成分浓度下,可用作非药物制剂(BAFS 或准药物);以药理学形式呈现,适合肠外、口服、外用或其他应用。INSC 的分子式为[(Ln (MeI3) +) y [Me (Lm) I] + x} (Cl-) y + x + k],M = 30-300 kDa。
  • Antibacterial agent for treating infectious diseases of bacterial origin
    申请人:Ilin Alexandr Ivanovich
    公开号:US10149890B2
    公开(公告)日:2018-12-11
    The invention relates to medicine, namely to the antimicrobial agent for the treatment of infectious bacterial diseases including hospital infections and drug-resistant TB which represents the ion nanostructured complex (INSC) synthesized from carbohydrates proteins and/or polypeptides (albumins, interleukins, interferons, signaling proteins, etc), which are to enhance the antimicrobial activity in vivo, by activating immune cells that contain at least one terminal amino acid such as Phe, Ala, Val, Ala, Leu, Ile, and others with electron-donor functional groups, iodine and halides of the alkali and alkaline earth elements in the fourth stage at a certain ionic strength; an antibacterial agent increases: the susceptibility of bacteria, including antibiotic-resistant, to antibiotics; activity of monocytes and macrophages; efficiency of antibiotic treatment of hospital infections and drug-resistant TB; it also has antiviral activity, stimulates hematopoietic function of bone marrow; has an antitumor effect and radioprotective properties; in acceptable concentrations of components can be used as non-pharmaceutical agent (BAFS or parapharmaceutical); is presented in the pharmacological form suitable for parenteral, oral, external, or other application. INSC has the formula [(Ln(MeI3)+)y[Me(Lm)I]+x}(Cl−)y+x+k] with M=30-300 kDa.
    本发明涉及医学,即用于治疗包括医院感染和耐药结核病在内的传染性细菌疾病的抗菌剂,它是由碳水化合物蛋白质和/或多肽(白蛋白、白细胞介素、干扰素、信号蛋白等)合成的离子纳米结构复合物(INSC),通过激活至少含有一个末端氨基酸(如Phe、Ala、Val、Ala、Leu、Iu)的免疫细胞,增强体内的抗菌活性、等)合成的纳米结构复合物(INSC),通过激活至少含有一个末端氨基酸(如 Phe、Ala、Val、Ala、Leu、Ile 等)的免疫细胞,使其在一定的离子强度下,在第四阶段具有电子供体功能基团、和碱及碱土元素的卤化物,从而增强体内的抗菌活性;增加抗菌剂:它还具有抗病毒活性,刺激骨髓造血功能;具有抗肿瘤作用和放射保护特性;在可接受的成分浓度下,可用作非药物制剂(BAFS 或准药物);以药理学形式呈现,适合肠外、口服、外用或其他应用。INSC 的分子式为[(Ln(MeI3)+)y[Me(Lm)I]+x}(Cl-)y+x+k],M=30-300 kDa。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸